Arikan-Akdagli S - Search Results

1

First multicentre report of in vitro resistance rates in candidaemia isolates in Turkey.

Arikan-Akdagli S, Gülmez D, Doğan Ö, Çerikçioğlu N, Doluca Dereli M, Birinci A, Yıldıran ŞT, Ener B, Öz Y, Metin DY, Hilmioğlu-Polat S, Kalkancı A, Koç N, Erturan Z, Fındık D. Arikan-Akdagli S, et al. J Glob Antimicrob Resist. 2019 Sep;18:230-234. doi: 10.1016/j.jgar.2019.04.003. Epub 2019 Apr 10. J Glob Antimicrob Resist. 2019. PMID: 30980958

2

Influence of serum on in vitro susceptibility testing of echinocandins for Candida parapsilosis and Candida guilliermondii.

Saribas Z, Yurdakul P, Cetin-Hazirolan G, Arikan-Akdagli S. Saribas Z, et al. Mycoses. 2012 Mar;55(2):156-60. doi: 10.1111/j.1439-0507.2011.02050.x. Epub 2011 Jun 12. Mycoses. 2012. PMID: 21668525

3

Distribution, virulence attributes and antifungal susceptibility patterns of Candida parapsilosis complex strains isolated from clinical samples.

Tosun I, Akyuz Z, Guler NC, Gulmez D, Bayramoglu G, Kaklikkaya N, Arikan-Akdagli S, Aydin F. Tosun I, et al. Med Mycol. 2013 Jul;51(5):483-92. doi: 10.3109/13693786.2012.745953. Epub 2012 Dec 6. Med Mycol. 2013. PMID: 23216051

4

Head-to-head comparison of inhibitory and fungicidal activities of fluconazole, itraconazole, voriconazole, posaconazole, and isavuconazole against clinical isolates of Trichosporon asahii.

Hazirolan G, Canton E, Sahin S, Arikan-Akdagli S. Hazirolan G, et al. Antimicrob Agents Chemother. 2013 Oct;57(10):4841-7. doi: 10.1128/AAC.00850-13. Epub 2013 Jul 22. Antimicrob Agents Chemother. 2013. PMID: 23877683 Free PMC article.

5

Candidaemia in a paediatric centre and importance of central venous catheter removal.

Karadag-Oncel E, Kara A, Ozsurekci Y, Arikan-Akdagli S, Cengiz AB, Ceyhan M, Gur D, Celik M, Ozkaya-Parlakay A. Karadag-Oncel E, et al. Mycoses. 2015 Mar;58(3):140-8. doi: 10.1111/myc.12288. Epub 2015 Feb 10. Mycoses. 2015. PMID: 25678411

6

Epidemiology of candidaemia in a tertiary care university hospital: 10-year experience with 381 candidaemia episodes between 2001 and 2010.

Alp S, Arikan-Akdagli S, Gulmez D, Ascioglu S, Uzun O, Akova M. Alp S, et al. Mycoses. 2015 Aug;58(8):498-505. doi: 10.1111/myc.12349. Epub 2015 Jul 7. Mycoses. 2015. PMID: 26155849

7

Evaluation of Antifungal Efficacy of 0.1% and 0.25% Riboflavin with UVA: A Comparative In Vitro Study.

Bilgihan K, Kalkanci A, Ozdemir HB, Yazar R, Karakurt F, Yuksel E, Otag F, Karabicak N, Arikan-Akdagli S. Bilgihan K, et al. Curr Eye Res. 2016 Aug;41(8):1050-1056. doi: 10.3109/02713683.2015.1088956. Epub 2015 Dec 7. Curr Eye Res. 2016. PMID: 26644282

8

[Evaluation of PNA-FISH method for direct identification of Candida species in blood culture samples and its potential impact on guidance of antifungal therapy].

Doğan Ö, İnkaya AÇ, Gülmez D, Uzun Ö, Akova M, Arıkan Akdağlı S. Doğan Ö, et al. Mikrobiyol Bul. 2016 Oct;50(4):580-589. doi: 10.5578/mb.27948. Mikrobiyol Bul. 2016. PMID: 28124963 Free article. Turkish.

9

In vitro activities of antifungal drugs against environmental Exophiala isolates and review of the literature.

Gülmez D, Doğan Ö, Boral B, Döğen A, İlkit M, de Hoog GS, Arikan-Akdagli S. Gülmez D, et al. Mycoses. 2018 Aug;61(8):561-569. doi: 10.1111/myc.12779. Epub 2018 Jun 13. Mycoses. 2018. PMID: 29611230 Review.

10

Antifungal susceptibility profiles of rare ascomycetous yeasts.

Pérez-Hansen A, Lass-Flörl C, Lackner M; Rare Yeast Study Group. Pérez-Hansen A, et al. J Antimicrob Chemother. 2019 Sep 1;74(9):2649-2656. doi: 10.1093/jac/dkz231. J Antimicrob Chemother. 2019. PMID: 31203366

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

85 results

Search Page